123 related articles for article (PubMed ID: 34950207)
81. MicroRNA-300 Inhibits the Proliferation and Metastasis of Cervical Cancer Cells via Posttranscriptional Suppression of G Protein-Coupled Receptor 34 (GPR34).
Wang M; Tian Y; Miao L; Zhao W
J Oncol; 2021; 2021():2669822. PubMed ID: 34950207
[TBL] [Abstract][Full Text] [Related]
82. MicroRNA-381 targets G protein-Coupled receptor 34 (GPR34) to regulate the growth, migration and invasion of human cervical cancer cells.
Tan Y; Wang H; Zhang C
Environ Toxicol Pharmacol; 2021 Jan; 81():103514. PubMed ID: 33086148
[TBL] [Abstract][Full Text] [Related]
83. G-protein coupled receptor 34 knockdown impairs the proliferation and migration of HGC-27 gastric cancer cells in vitro.
Jin ZT; Li K; Li M; Ren ZG; Wang FS; Zhu JY; Leng XS; Yu WD
Chin Med J (Engl); 2015 Feb; 128(4):545-9. PubMed ID: 25673461
[TBL] [Abstract][Full Text] [Related]
84. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
Yu W; Ma S; Wang L; Zuo B; Li M; Qiao Z; Pan X; Liu Y; Wang J
Histol Histopathol; 2013 Dec; 28(12):1629-38. PubMed ID: 23836308
[TBL] [Abstract][Full Text] [Related]
85. MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer.
Zhou N; Fei D; Zong S; Zhang M; Yue Y
Oncol Lett; 2016 Nov; 12(5):3633-3639. PubMed ID: 27900047
[TBL] [Abstract][Full Text] [Related]
86. miR-584 inhibits cell proliferation, migration and invasion
Wang T; Feng J; Zhang A
Exp Ther Med; 2020 Mar; 19(3):2059-2066. PubMed ID: 32104266
[TBL] [Abstract][Full Text] [Related]
87. [MiR-300 inhibits invasion and metastasis of osteosarcoma cell MG63 by negatively regulating PTTG1].
Liang D; Wu X; Bai J; Zhang L; Yin C; Zhong W
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Feb; 41(2):285-291. PubMed ID: 33624604
[TBL] [Abstract][Full Text] [Related]
88. miR-300/FA2H affects gastric cancer cell proliferation and apoptosis.
Hong B; Li J; Huang C; Huang T; Zhang M; Huang L
Open Med (Wars); 2020; 15(1):882-889. PubMed ID: 33344772
[TBL] [Abstract][Full Text] [Related]
89. Impact of the Learning Curve on the Survival of Abdominal or Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
Li LY; Wen LY; Park SH; Nam EJ; Lee JY; Kim S; Kim YT; Kim SW
Cancer Res Treat; 2021 Jan; 53(1):243-251. PubMed ID: 33070554
[TBL] [Abstract][Full Text] [Related]
90. TILs and Anti-PD1 Therapy: An Alternative Combination Therapy for PDL1 Negative Metastatic Cervical Cancer.
Yin H; Guo W; Sun X; Li R; Feng C; Tan Y
J Immunol Res; 2020; 2020():8345235. PubMed ID: 32964058
[TBL] [Abstract][Full Text] [Related]
91. LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression.
Zhao D; Zhang H; Long J; Li M
Onco Targets Ther; 2020; 13():1677-1689. PubMed ID: 32161467
[TBL] [Abstract][Full Text] [Related]
92. MiRNA-300 suppresses proliferation, migration and invasion of non-small cell lung cancer via targeting ETS1.
Yang YB; Tan H; Wang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10827-10834. PubMed ID: 31858551
[TBL] [Abstract][Full Text] [Related]
93. RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.
Wu H; Song S; Yan A; Guo X; Chang L; Xu L; Hu L; Kuang M; Liu B; He D; Zhao R; Wang L; Wu X; Gu J; Ruan Y
Cancer Lett; 2020 Jan; 469():287-300. PubMed ID: 31705928
[TBL] [Abstract][Full Text] [Related]
94. Small Regulatory Molecules Acting Big in Cancer: Potential Role of Mito-miRs in Cancer.
Sharma P; Bharat ; Dogra N; Singh S
Curr Mol Med; 2019; 19(9):621-631. PubMed ID: 31340735
[TBL] [Abstract][Full Text] [Related]
95. MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway.
Yan H; Li J; Ying Y; Xie H; Chen H; Xu X; Zheng X
Cell Cycle; 2018; 17(24):2790-2801. PubMed ID: 30526300
[TBL] [Abstract][Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
